Eduard Berenshtein Selected Research

zinc-desferrioxamine

10/2011	Zinc-desferrioxamine attenuates retinal degeneration in the rd10 mouse model of retinitis pigmentosa.
5/2005	Treatment of ocular tissues exposed to nitrogen mustard: beneficial effect of zinc desferrioxamine combined with steroids.
7/2003	Injury induced by chemical warfare agents: characterization and treatment of ocular tissues exposed to nitrogen mustard.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Eduard Berenshtein Research Topics

Disease

9	Ischemia 01/2016 - 05/2002
5	Inflammation (Inflammations) 01/2014 - 07/2003
3	Macular Degeneration (Age-Related Maculopathy) 01/2014 - 12/2009
3	Retinal Degeneration 01/2014 - 12/2009
2	Infarction (Infarctions) 01/2016 - 07/2006
2	Reperfusion Injury 01/2016 - 12/2008
2	Myocardial Ischemia (Ischemic Heart Diseases) 12/2008 - 07/2006
2	Cicatrix (Scar) 10/2008 - 07/2003
2	Colitis 01/2008 - 10/2004
2	Wounds and Injuries (Trauma) 05/2005 - 07/2003
1	Hyperglycemia 01/2016
1	Asthma (Bronchial Asthma) 01/2014
1	Dental Plaque 05/2013
1	Hypoxia (Hypoxemia) 01/2012
1	Retinitis Pigmentosa (Pigmentary Retinopathy) 10/2011
1	Nasal Polyps (Nasal Polyp) 03/2011
1	Infections 10/2008
1	Type 2 Diabetes Mellitus (MODY) 01/2007
1	Neoplasms (Cancer) 01/2007
1	Atherosclerosis 01/2007
1	Corneal Neovascularization 05/2005
1	Myocardial Reperfusion Injury 05/2002

Drug/Important Bio-Agent (IBA)

10	IronIBA 01/2016 - 05/2002
7	Ferritins (Ferritin)IBA 01/2016 - 04/2008
4	Free RadicalsIBA 04/2008 - 07/2003
3	Retinaldehyde (Retinal)IBA 01/2014 - 04/2008
3	zinc-desferrioxamineIBA 10/2011 - 07/2003
2	Methionine (L-Methionine)FDA Link 01/2016 - 03/2011
2	CopperIBA 01/2016 - 05/2002
2	Proteins (Proteins, Gene)FDA Link 01/2016 - 03/2011
2	Hydroxyl RadicalIBA 01/2014 - 07/2006
2	ApoferritinsIBA 01/2012 - 12/2008
1	Sucrose (Saccharose)IBA 01/2016
1	Aconitate Hydratase (Aconitase)IBA 01/2016
1	Aluminum Hydroxide (Algeldrate)FDA Link 01/2014
1	OvalbuminIBA 01/2014
1	Coloring Agents (Dyes)IBA 05/2013
1	CalciumIBA 05/2013
1	Phosphorus (Red Phosphorus)IBA 05/2013
1	NAD (NADH)IBA 01/2012
1	EnzymesIBA 01/2012
1	4-Aminobenzoic Acid (4 Aminobenzoic Acid)IBA 12/2009
1	Messenger RNA (mRNA)IBA 12/2008
1	Gentamicins (Gentamicin)FDA LinkGeneric 10/2008
1	Anti-Bacterial Agents (Antibiotics)IBA 10/2008
1	sym-trinitrobenzeneIBA 01/2008
1	Sulfonic AcidsIBA 01/2008
1	Substance PIBA 01/2008
1	cannabidiol hydroxyquinone (HU331)IBA 01/2007
1	AnthracyclinesIBA 01/2007
1	Insulin (Novolin)FDA Link 01/2007
1	Reactive Oxygen Species (Oxygen Radicals)IBA 01/2007
1	CaspasesIBA 01/2007
1	ChloridesIBA 07/2006
1	Midazolam (Versed)FDA LinkGeneric 07/2006
1	GABA-A Receptors (GABA(A) Receptor)IBA 07/2006
1	Flumazenil (Romazicon)FDA LinkGeneric 07/2006
1	SalicylatesIBA 07/2006
1	Mustard Gas (Sulfur Mustard)IBA 05/2005
1	Dexamethasone (Maxidex)FDA LinkGeneric 05/2005
1	Glutamine (L-Glutamine)FDA Link 10/2004
1	AntioxidantsIBA 10/2004
1	Phosphates (Orthophosphate)IBA 10/2004
1	AcidsIBA 10/2004
1	Peroxidase (Myeloperoxidase)IBA 10/2004
1	MetalsIBA 07/2003
1	Krebs-Henseleit solutionIBA 05/2002
1	nitroxylIBA 05/2002

Therapy/Procedure

2	Therapeutics 10/2008 - 01/2007
1	Topical Administration 10/2008
1	Enema (Enemas) 10/2004